VEGF is also augmented by mediators produced by TAM and tumor cells 11 such as transforming growth factor beta 1 (TGFβ1) and other factors, such as IL-13, IL-4, and IL-10 6, skewing the macrophage response toward an M2 phenotype. This evidence concerns the gene VEGFA and neoplasm.